Bon Natural Life Limited (BON)
NASDAQ: BON · Real-Time Price · USD
0.0616
+0.0031 (5.30%)
At close: Apr 24, 2025, 4:00 PM
0.0600
-0.0016 (-2.60%)
Pre-market: Apr 25, 2025, 5:59 AM EDT
Company Description
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People’s Republic of China and internationally.
The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements.
Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries.
Bon Natural Life Limited was founded in 2006 and is based in Xi'an, the People’s Republic of China.
Bon Natural Life Limited
| Country | China |
| Founded | 2006 |
| IPO Date | Jun 24, 2021 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 97 |
| CEO | Yongwei Hu |
Contact Details
Address: Block C, Gazelle Valley, Room 601 Xi'an China | |
| Website | bnlus.com |
Stock Details
| Ticker Symbol | BON |
| Exchange | NASDAQ |
| Share Class | Class A Shares |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001816815 |
| CUSIP Number | G14492105 |
| ISIN Number | KYG144921056 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Yongwei Hu | Chairman and Chief Executive Officer |
| Wang L. Lee | Chief Financial Officer |
| Yingchun Xue | Chief Operating Officer |
| Jianli Liu | Chief Technology Officer and Chief Scientist |
| Wenjuan Chen | Chief Marketing Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 23, 2025 | 6-K | Report of foreign issuer |
| Apr 16, 2025 | 20-F/A | Filing |
| Apr 11, 2025 | 6-K | Report of foreign issuer |
| Apr 3, 2025 | 6-K | Report of foreign issuer |
| Apr 2, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 27, 2025 | SCHEDULE 13G/A | Filing |
| Mar 21, 2025 | SCHEDULE 13G/A | Filing |
| Mar 18, 2025 | 424B4 | Prospectus |
| Mar 17, 2025 | 6-K | Report of foreign issuer |
| Mar 17, 2025 | SCHEDULE 13G | Filing |